Project Details
Description
A Phase II, Open Label Study of ONC201 in Adults with EGFR-low glioblastoma
| Status | Active |
|---|---|
| Effective start/end date | 7/2/21 → 6/30/26 |
Funding
- CHIMERIX, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.